Article

The Molecular Landscape and Utility of Multiomic Analyses in Triple Negative Breast Cancer: Further Subtyping and Exploring Novel Biomarkers and Therapeutic Targets

2025-10-09

Abstract excerpt

Triple-negative breast cancer (TNBC) has the poorest prognosis among all breast cancer subtypes, largely due to the lack of targeted therapies and its resistance to both chemotherapy and immunotherapy. A deeper understanding of TNBC biology is therefore critical for identifying therapeutic targets. Molecular subtyping of TNBC, first introduced over a decade ago, has significantly advanced our knowledge of the dise...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: a6fa92bb-097d-5889-a6b4-9b22da837c09
DOI: 10.20944/preprints202510.0714.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The Molecular Landscape and Utility of Multiomic Analyses in Triple Negative Breast Cancer: Further Subtyping and Exploring Novel Biomarkers and Therapeutic TargetsDOI 10.20944/preprints202510.0714.v1Read

Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapiesSemantic proximity Read

Triple negative breast cancer (TNBC): Non-genetic tumor heterogeneity and immune microenvironment: Emerging treatment optionsSemantic proximity Read

Pathogenesis of Triple-Negative Breast CancerSemantic proximity Read

Unravelling triple-negative breast cancer molecular heterogeneity using an integrative multiomic analysis.Semantic proximity Read

Update on triple‐negative breast cancers – highlighting subtyping update and treatment implicationSemantic proximity Read

The Proteomic Landscape of Triple-Negative Breast CancerSemantic proximity Read

Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease.Semantic proximity Read

Clinical implications of molecular heterogeneity in triple negative breast cancer.Semantic proximity Read

Targeting the Molecular Subtypes of Triple Negative Breast Cancer: Understanding the Diversity to Progress the Field.Semantic proximity Read

The Omics of Triple-Negative Breast CancersSemantic proximity Read

Molecular Classification and Future Therapeutic Challenges of Triple-negative Breast CancerSemantic proximity Read

Kinome profiling reveals breast cancer heterogeneity and identifies targeted therapeutic opportunities for triple negative breast cancerSemantic proximity Read